Women’s Stories CDC Bring Your Brave Campaign, 2019

Main|Search|PHGKB




Last Posted: May 10, 2019

---

• Women’s Stories
  CDC Bring Your Brave Campaign, 2019
• A multigene assay determines risk of recurrence in patients with triple-negative breast cancer.
  Stewart Rachel L et al. Cancer research 2019 May
• ClinOmicsTrail
  A visual analytics tool for breast cancer treatment stratification using multi-omics data
• ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification.
  Schneider Lara et al. Bioinformatics (Oxford, England) 2019 Apr
• Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
  Pilewskie Melissa et al. Breast cancer research and treatment 2019 May 175(1) 141-148
• Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial.
  Loibl Sibylle et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Apr
• Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.
  Lazaridis Georgios et al. Cancer genomics & proteomics 16(3) 195-206
• The Prognostic Significance of the Oncotype DX Recurrence Score in T 1-2 N 1 M 0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition.
  Wang Maoli et al. Annals of surgical oncology 2019 May 26(5) 1227-1235
• A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
  Yala Adam et al. Radiology 2019 May 182716
• Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
  Nomura Hidetaka et al. International journal of clinical oncology 2019 May

more